Average Co-Inventor Count = 6.52
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Dana-farber-cancer Institute Inc. (7 from 1,209 patents)
2. The General Hospital Corporation (6 from 2,893 patents)
3. Other (1 from 832,843 patents)
4. The University of Texas System (1 from 5,450 patents)
5. The University of North Carolina at Chapel Hill (1 from 1,271 patents)
8 patents:
1. 12006555 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
2. 11009508 - Methods of diagnosing and prognosing lung cancer
3. 10669589 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
4. 10172581 - Methods of assessing tumor growth
5. 10000815 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
6. 9119379 - Systems and methods for detecting estrus
7. 9035036 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments
8. 7294468 - Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments